Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AVHINASDAQ:BTTXNYSE:FORNASDAQ:KDLY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVHIAV Homes$11.20$0.00$15.55▼$22.02$31.47M0.06509 shsN/ABTTXBetter Therapeutics$0.00$0.00$0.00▼$0.02$5K0.9517,738 shs47,232 shsFORForestar Group$21.73-0.4%$19.83$18.00▼$37.21$1.11B1.4175,510 shs85,024 shsKDLYKindly MD$13.12-3.6%$13.54$0.65▼$34.77$79.01MN/A2.16 million shs473,562 shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVHIAV Homes0.00%0.00%0.00%0.00%-0.88%BTTXBetter Therapeutics0.00%0.00%0.00%-75.00%-99.00%FORForestar Group-0.48%+9.60%+9.90%+2.67%-28.28%KDLYKindly MD-3.60%-7.08%-38.37%+786.49%+433.33%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAVHIAV HomesN/AN/AN/AN/AN/AN/AN/AN/ABTTXBetter TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AFORForestar Group4.1917 of 5 stars3.32.00.02.11.10.83.1KDLYKindly MDN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAVHIAV Homes 0.00N/AN/AN/ABTTXBetter Therapeutics 0.00N/AN/AN/AFORForestar Group 2.67Moderate Buy$30.3339.59% UpsideKDLYKindly MD 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest AVHI, FOR, KDLY, and BTTX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/21/2025FORForestar GroupBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$36.00 ➝ $29.00(Data available from 7/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAVHIAV HomesN/AN/AN/AN/A($2.46) per shareN/ABTTXBetter TherapeuticsN/AN/AN/AN/AN/AN/AFORForestar Group$1.51B0.73$4.06 per share5.35$31.49 per share0.69KDLYKindly MD$2.47M31.98N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAVHIAV Homes-$2.58M-$1.23N/A∞N/AN/AN/A-38.71%N/ABTTXBetter Therapeutics-$39.76MN/A0.00∞N/AN/AN/AN/A7/21/2025 (Estimated)FORForestar Group$203.40M$3.306.585.83N/A11.45%10.65%5.89%7/22/2025 (Estimated)KDLYKindly MDN/A-$0.77N/A∞N/AN/AN/AN/AN/ALatest AVHI, FOR, KDLY, and BTTX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/22/2025Q3 2025FORForestar Group$0.78N/AN/AN/A$397.50 millionN/A5/8/2025Q1 2025KDLYKindly MDN/A-$0.17N/A-$0.17N/AN/A4/17/2025Q2 2025FORForestar Group$0.71$0.64-$0.07$0.62$379.60 million$351.00 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAVHIAV HomesN/AN/AN/AN/AN/ABTTXBetter TherapeuticsN/AN/AN/AN/AN/AFORForestar GroupN/AN/AN/AN/AN/AKDLYKindly MDN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAVHIAV HomesN/AN/AN/ABTTXBetter TherapeuticsN/AN/AN/AFORForestar Group0.530.730.73KDLYKindly MDN/A5.435.42Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAVHIAV Homes16.30%BTTXBetter Therapeutics34.00%FORForestar Group35.50%KDLYKindly MDN/AInsider OwnershipCompanyInsider OwnershipAVHIAV Homes51.50%BTTXBetter Therapeutics51.40%FORForestar Group0.40%KDLYKindly MD50.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAVHIAV HomesN/A2.81 million1.36 millionNot OptionableBTTXBetter Therapeutics4049.86 million24.23 millionOptionableFORForestar Group29050.82 million50.62 millionOptionableKDLYKindly MDN/A6.02 million2.96 millionN/AAVHI, FOR, KDLY, and BTTX HeadlinesRecent News About These CompaniesKindly MD (NASDAQ:KDLY) Stock Price Down 6.1% - Time to Sell?June 26, 2025 | marketbeat.comReed Smith Advises Anthony Pompliano and ProCap Financial in Historic $750 million Bitcoin Treasury RaiseJune 23, 2025 | prnewswire.comNAKA Kindly MD, Inc.May 31, 2025 | seekingalpha.comNakamoto Holdings, Kindly MD, Anchorage Digital Announce Strategic Bitcoin Treasury PartnershipMay 26, 2025 | crowdfundinsider.comCKindly MD Changes Ticker Symbols Amid MergerMay 23, 2025 | tipranks.comAnchorage Digital named exclusive custodian for KindlyMD Bitcoin assetsMay 22, 2025 | investing.comKindlyMD Stock Soars After Shareholders Approve Bitcoin Treasury Strategy With Nakamoto Merger Led By Trump Crypto AdvisorMay 21, 2025 | msn.comNakamoto Holdings, Kindly MD, and Anchorage Digital Form Strategic Bitcoin Treasury PartnershipMay 21, 2025 | accessnewswire.comAKindlyMD Shareholders Approve Proposed Merger with Nakamoto HoldingsMay 21, 2025 | finanznachrichten.deKindlyMD shareholders approve Nakamoto mergerMay 21, 2025 | investing.comSurprising stock jumps over 30% after SEC confirms mergerMay 21, 2025 | msn.comKindlyMD® Shareholders Approve Proposed Merger with Nakamoto HoldingsMay 20, 2025 | businesswire.comKindly MD, Inc. Updates Executive Employment AgreementsMay 16, 2025 | tipranks.comKindlyMD Wants to Become the Next MicroStrategy. Should You Buy KDLY Stock Now for Its Bitcoin Treasury and Trump Ties?May 15, 2025 | msn.comKindlyMD Skyrockets on Merger With Nakamoto to Make Bitcoin TreasuryMay 13, 2025 | marketwatch.comKindlyMD, Nakamoto Holdings to Merge, Pursue Global Bitcoin Treasury Strategy, Shares Rocket HigherMay 12, 2025 | crowdfundinsider.comCNakamoto Holdings Raises $710M, Merges With KindlyMD To Build Bitcoin Treasury Holding CompanyMay 12, 2025 | benzinga.comTarget, Astera Labs, Kindly MD: Trending TickersMay 12, 2025 | finance.yahoo.comKindlyMD Stock Surges To All-Time High After Announcing Merger With Nakamoto To Launch Bitcoin Treasury StrategyMay 12, 2025 | msn.comA 600% rally: How Bitcoin sent this healthcare stock soaringMay 12, 2025 | invezz.comIKindly MD First Quarter 2025 Earnings: US$0.17 loss per share (vs US$0.061 loss in 1Q 2024)May 12, 2025 | uk.finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir Soon3 Stocks Getting Rare Double Upgrades From AnalystsBy Chris Markoch | June 6, 2025View 3 Stocks Getting Rare Double Upgrades From Analysts3 Industrials Stocks Standing Out for Growth and Analyst OptimismBy Nathan Reiff | June 4, 2025View 3 Industrials Stocks Standing Out for Growth and Analyst Optimism3 Reasons AMD Could Be the Hottest Stock of the SummerBy Sam Quirke | June 20, 2025View 3 Reasons AMD Could Be the Hottest Stock of the SummerBreakout Momentum Plays You May Not Know AboutBy Nathan Reiff | June 6, 2025View Breakout Momentum Plays You May Not Know AboutAVHI, FOR, KDLY, and BTTX Company DescriptionsAV Homes NASDAQ:AVHIAV Homes, Inc. engages in the homebuilding and community development businesses in Florida, the Carolinas, Arizona, and Texas markets. The company is involved in the acquisition, development, and building of active adult communities, which are age-restricted to the age 55 and over active adult demographic; and primary residential home communities under local Savvy Homes, Bonterra Builders, Royal Oak Homes, and Oakdale-Hampton brands for first-time and move-up buyers. It also engages in the construction and sale of residences within the communities. In addition, the company is involved in other real estate activities, such as the operation of amenities; and the sale of land for third-party development. As of December 31, 2017, it owned 4,911 developed residential lots; 2,395 partially developed residential lots; 8,776 undeveloped residential lots; and 6,980 acres of mixed-use, commercial, and industrial land. The company was formerly known as Avatar Holdings Inc. and changed its name to AV Homes, Inc. in February 2012. AV Homes, Inc. was founded in 1970 and is headquartered in Scottsdale, Arizona.Better Therapeutics NASDAQ:BTTX$0.0001 0.00 (0.00%) As of 07/2/2025 10:44 AM EasternBetter Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company's clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.Forestar Group NYSE:FOR$21.73 -0.08 (-0.37%) As of 07/3/2025 03:30 PM EasternForestar Group Inc. operates as a residential lot development company in the United States. The company acquires land and develops infrastructure for single-family residential communities. It sells its residential single-family finished lots to local, regional, and national homebuilders. The company was incorporated in 2005 and is headquartered in Arlington, Texas. Forestar Group Inc. operates as a subsidiary of D.R. Horton, Inc.Kindly MD NASDAQ:KDLY$13.12 -0.49 (-3.60%) As of 07/2/2025Kindly MD, Inc. provides healthcare services. Its services include medication management, behavioral healthcare and alternative treatments. The firm offers evaluation and management, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy. The company was founded by Timothy Pickett in December 2019 and is headquartered in Murray, UT. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Rocket Lab: Latest Catalysts Bolster the Bull Case Nike's Stock Just Got an Upgrade: Is a Real Comeback Brewing? Why Hims & Hers Is a Buy Below $35 After Its 16% Pullback Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
